Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -0.28 |
peg ratio | -0.00 |
price to book ratio | 1.25 |
price to sales ratio | 63.23 |
enterprise value multiple | 0.06 |
price fair value | 1.25 |
profitability ratios | |
---|---|
gross profit margin | -1221.92% |
operating profit margin | -19008.71% |
pretax profit margin | -21281.68% |
net profit margin | -21290.09% |
return on assets | -122.83% |
return on equity | -154.84% |
return on capital employed | -130.09% |
liquidity ratio | |
---|---|
current ratio | 1.92 |
quick ratio | 1.92 |
cash ratio | 1.16 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 81.11 |
days of payables outstanding | 65.75 |
cash conversion cycle | 15.36 |
receivables turnover | 4.50 |
payables turnover | 5.55 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.60 |
debt equity ratio | 2.17 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.68 |
interest coverage | -56.92 |
cash flow to debt ratio | -1.01 |
cash flow ratios | |
---|---|
free cash flow per share | -7.64 |
cash per share | 2.29 |
operating cash flow per share | -7.63 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | -1.01 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -1,838.42 |
Frequently Asked Questions
Senti Biosciences, Inc. (SNTI) published its most recent earnings results on 14-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Senti Biosciences, Inc. (NASDAQ:SNTI)'s trailing twelve months ROE is -154.84%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Senti Biosciences, Inc. (SNTI) currently has a ROA of -122.83%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
SNTI reported a profit margin of -21290.09% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.92 in the most recent quarter. The quick ratio stood at 1.92, with a Debt/Eq ratio of 2.17.